Janus kinase inhibitor, tofacitinib, in refractory juvenile dermatomyositis: a retrospective multi-central study in China

OBJECTIVES: Juvenile dermatomyositis (JDM) is a chronic autoimmune disease. Some patients remain in an active state even though they were administrated with a combination of corticosteroid and methotrexate. Existing research has suggested that interferon and Janus kinase played an important role in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Junmei, Sun, Li, Shi, XinWei, Li, Shipeng, Liu, Cuihua, Li, Xiaoqing, Lu, Meiping, Deng, Jianghong, Tan, Xiaohua, Guan, Wanzhen, Li, Guomin, Wen, Xinran, Liu, Ping, Li, Caifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583374/
https://www.ncbi.nlm.nih.gov/pubmed/37853451
http://dx.doi.org/10.1186/s13075-023-03170-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583374/
https://www.ncbi.nlm.nih.gov/pubmed/37853451
http://dx.doi.org/10.1186/s13075-023-03170-z

Ejemplares similares